We should have LP002 "bridge data" within a week. Gerald indicated that following that there would be something "concrete" done regarding our Lympro partnership that would increase shareholder value. I don't believe it is a JV Partnership, but it will be something that will give us more value. In any regard, he tied it to the LP002 release of data. I don't know how long afterward this other thing will happen.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links